NEO
Price
$7.99
Change
-$0.07 (-0.87%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
1.04B
67 days until earnings call
RGEN
Price
$124.56
Change
+$3.98 (+3.30%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
6.78B
60 days until earnings call
Interact to see
Advertisement

NEO vs RGEN

Header iconNEO vs RGEN Comparison
Open Charts NEO vs RGENBanner chart's image
NeoGenomics
Price$7.99
Change-$0.07 (-0.87%)
Volume$19.05K
Capitalization1.04B
Repligen
Price$124.56
Change+$3.98 (+3.30%)
Volume$27.41K
Capitalization6.78B
NEO vs RGEN Comparison Chart in %
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. RGEN commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Buy and RGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (NEO: $8.06 vs. RGEN: $120.58)
Brand notoriety: NEO and RGEN are both not notable
NEO represents the Medical Specialties, while RGEN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NEO: 105% vs. RGEN: 107%
Market capitalization -- NEO: $1.04B vs. RGEN: $6.78B
NEO [@Medical Specialties] is valued at $1.04B. RGEN’s [@Pharmaceuticals: Other] market capitalization is $6.78B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, NEO is a better buy in the long-term than RGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 6 TA indicator(s) are bullish while RGEN’s TA Score has 3 bullish TA indicator(s).

  • NEO’s TA Score: 6 bullish, 4 bearish.
  • RGEN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NEO is a better buy in the short-term than RGEN.

Price Growth

NEO (@Medical Specialties) experienced а +11.79% price change this week, while RGEN (@Pharmaceuticals: Other) price change was -1.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.22%. For the same industry, the average monthly price growth was +6.83%, and the average quarterly price growth was +11.96%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

Reported Earning Dates

NEO is expected to report earnings on Nov 11, 2025.

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEN($6.78B) has a higher market cap than NEO($1.04B). RGEN YTD gains are higher at: -16.229 vs. NEO (-51.092). RGEN has higher annual earnings (EBITDA): 99.5M vs. NEO (-28.47M). RGEN has more cash in the bank: 709M vs. NEO (164M). NEO has less debt than RGEN: NEO (412M) vs RGEN (686M). NEO (689M) and RGEN (674M) have equivalent revenues.
NEORGENNEO / RGEN
Capitalization1.04B6.78B15%
EBITDA-28.47M99.5M-29%
Gain YTD-51.092-16.229315%
P/E RatioN/A521.44-
Revenue689M674M102%
Total Cash164M709M23%
Total Debt412M686M60%
FUNDAMENTALS RATINGS
NEO vs RGEN: Fundamental Ratings
NEO
RGEN
OUTLOOK RATING
1..100
2358
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
4579
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (64) in the Medical Or Nursing Services industry is in the same range as RGEN (95) in the Biotechnology industry. This means that NEO’s stock grew similarly to RGEN’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as RGEN (100) in the Biotechnology industry. This means that NEO’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's SMR Rating (92) in the Biotechnology industry is in the same range as NEO (95) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

NEO's Price Growth Rating (45) in the Medical Or Nursing Services industry is somewhat better than the same rating for RGEN (79) in the Biotechnology industry. This means that NEO’s stock grew somewhat faster than RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEORGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNLRX64.760.59
+0.92%
BNY Mellon Active MidCap I
VFFSX318.822.67
+0.84%
Vanguard 500 Index Institutional Select
ZVNIX42.810.35
+0.82%
Zevenbergen Growth Institutional
FKIDX16.61N/A
N/A
Fidelity Diversified Intl K6
ETIHX40.09-0.11
-0.27%
Eventide Healthcare & Life Sciences I

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-1.59%
RGEN - NEO
38%
Loosely correlated
+3.79%
FLGT - NEO
37%
Loosely correlated
-0.18%
VCYT - NEO
36%
Loosely correlated
+2.94%
NNOX - NEO
36%
Loosely correlated
-0.80%
TWST - NEO
35%
Loosely correlated
-1.42%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
+3.79%
DHR - RGEN
67%
Closely correlated
-0.21%
A - RGEN
66%
Loosely correlated
+2.60%
BIO - RGEN
63%
Loosely correlated
+0.48%
MTD - RGEN
61%
Loosely correlated
+1.51%
BLFS - RGEN
59%
Loosely correlated
+3.31%
More